Search

Zealand Pharma A-S

Închisă

230.5 -0.47

Rezumat

Modificarea prețului

24h

Curent

Minim

229.8

Maxim

234.1

Indicatori cheie

By Trading Economics

Venit

4.3B

3.9B

Vânzări

4.5B

4.5B

P/E

Medie Sector

5.71

50.373

EPS

55.34

Marjă de profit

87.219

Angajați

578

EBITDA

4.2B

3.9B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+25.15% upside

Dividende

By Acuity

Următoarele câștiguri

12 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-7.5B

15B

Deschiderea anterioară

230.97

Închiderea anterioară

230.5

Zealand Pharma A-S Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

1 nov. 2026, 23:51 UTC

South Korea's October Manufacturing PMI Release on November 2 Expected to Reflect Mixed Sentiment Amid Global Economic Pressures.

1 nov. 2026, 23:51 UTC

Australia's Building Permits MoM data for September 2026 expected to rise by 2.1% amid cautious market sentiment and ongoing economic pressures.

1 nov. 2026, 23:51 UTC

Upcoming ISM Manufacturing Employment Report on November 2, 2026, Expected to Reflect Cautious Sentiment Amid Global Economic Uncertainties.

1 nov. 2026, 23:11 UTC

Macro News
Correlated Moves

Gold prices are advancing, supported by rising crude oil prices and increased investor interest in safe-haven assets amid geopolitical tensions in the Middle East.

1 nov. 2026, 23:11 UTC

Macro News
Correlated Moves

Silver prices are advancing amid rising crude oil prices and geopolitical tensions, as investors seek safe-haven assets in response to global equity market declines.

1 nov. 2026, 23:11 UTC

Brazil's Industrial Production Expected to Decline by 0.2% in September Amid Economic Concerns

1 nov. 2026, 23:11 UTC

Australia's Balance of Trade Expected to Show AUD 1.2 Billion Surplus for September Amid Global Economic Uncertainties

1 nov. 2026, 23:11 UTC

Macro News

The Dow Jones Industrial Average is advancing today, recovering from Friday's selloff amid geopolitical tensions and rising oil prices, despite earlier session pullbacks.

1 nov. 2026, 23:11 UTC

Macro News

The S&P 500 Index is modestly higher despite significant declines in global equity markets and rising oil prices amid geopolitical tensions in the Middle East.

1 nov. 2026, 23:11 UTC

Macro News

Natural gas prices are advancing sharply amid rising crude oil prices and fears of supply disruptions linked to ongoing conflicts involving Iran.

1 nov. 2026, 23:11 UTC

The EUR/JPY is trading higher at the start of the new week, despite broader market apprehension following a significant U.S. stock selloff on Friday.

1 nov. 2026, 23:11 UTC

Macro News
Correlated Moves

Platinum is trading modestly higher as crude oil prices surge amid supply disruption fears linked to ongoing conflicts in the Middle East.

1 nov. 2026, 23:11 UTC

Macro News

The Nasdaq 100 Index is advancing, showing a modest increase despite significant declines in global equity markets amid rising oil prices and geopolitical tensions.

1 nov. 2026, 23:11 UTC

Macro News

The Russell 2000 Index is modestly higher, gaining ground despite significant declines in major U.S. indices amid rising oil prices and geopolitical tensions.

1 nov. 2026, 23:01 UTC

Macro News

The Australian dollar is under pressure amid rising fuel prices and potential $700 million losses at Alaska Air, showing weakness in early trading.

1 nov. 2026, 23:01 UTC

The GBP/AUD is advancing as the new trading week begins, showing resilience amid recent volatility in U.S. equity markets.

1 nov. 2026, 23:01 UTC

The EUR/AUD is advancing in early trading as the new week begins, following a flat performance since Friday's close.

1 nov. 2026, 23:01 UTC

The EUR/CZK is advancing in early trading, showing a slight uptick since Friday's close amid a cautious investor outlook following U.S. market volatility.

1 nov. 2026, 23:01 UTC

The EUR/PLN is advancing in early trading this week, positioned near the upper end of its one-month range amid broader market volatility.

1 nov. 2026, 22:51 UTC

UK MPC Meeting Minutes on November 5, 2026: Investors Brace for Insights on Interest Rate Changes Amid Rising Inflation and Geopolitical Tensions.

1 nov. 2026, 22:31 UTC

Mexican Consumer Confidence Index Set for November 4 Release Amid Ongoing Economic Concerns and Weak Sentiment.

1 nov. 2026, 22:11 UTC

Mexico's Business Confidence Data Release on November 3, 2026 Expected to Show Continued Pessimism Amidst Stagnant Manufacturing Trends.

1 nov. 2026, 22:11 UTC

Brazil's Central Bank to announce interest rate decisions on November 3, 2026, amid cautious economic sentiment and inflation concerns.

1 nov. 2026, 22:01 UTC

Mortgage Rates Decline to 7.37%, Offering Hope for Homebuyers Amid High Prices and Cautious Market Sentiment Ahead of November Data Release

1 nov. 2026, 21:41 UTC

Turkey's Balance of Trade Data Release on November 4 Expected to Highlight Ongoing Trade Deficit Amid Economic Optimism and Geopolitical Tensions.

1 nov. 2026, 21:41 UTC

Australia's Ai Group Industry Index set for release on November 3 amid cautious market expectations following a significant decline and ongoing investor concerns in the tech sector.

1 nov. 2026, 21:31 UTC

Euro Area Retail Sales Expected to Decline by 0.1% Amid Economic Uncertainty and Rising Inflation, with Implications for GDP Growth and Monetary Policy

1 nov. 2026, 21:31 UTC

France's Industrial Production MoM data for September 2026 set to release on November 5, with a cautious market anticipating only a modest increase of 0.5% amid rising borrowing costs and negative fiscal outlook.

1 nov. 2026, 21:31 UTC

France's Trade Deficit Expected at €5.8 Billion Amid Negative Outlook and Economic Concerns Ahead of November 6 Report

1 nov. 2026, 21:31 UTC

Italy's Retail Sales MoM report on November 5 forecasts a modest 0.2% increase amid fluctuating consumer spending trends and inflationary pressures.

Zealand Pharma A-S Așteptări

Obiectiv de preț

By TipRanks

25.15% sus

Prognoză pe 12 luni

Medie 270.582 DKK  25.15%

Maxim 270.568 DKK

Minim 270.568 DKK

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruZealand Pharma A-S - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

1 ratings

0

Cumpărare

1

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Zealand Pharma A-S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.
help-icon Live chat